Abstract
Purpose Children undergoing stereoelectroencephalography (SEEG)-guided epilepsy surgery represent a complex cohort. We aimed to determine whether the proportion of putative seizure onset zone (SOZ) contacts resected associates with seizure outcome in a cohort of children undergoing SEEG-guided resective epilepsy surgery.
Methods Patients who underwent SEEG-guided resective surgery over a six-year period were included. The proportion of SOZ contacts resected was determined by co-registration of pre- and post-operative imaging. Seizure outcomes were classified as seizure free (SF, Engel class I) or not seizure-free (NSF, Engel class II-IV) at last clinical follow-up.
Results Of 94 patients undergoing SEEG, 29 underwent subsequent focal resection of whom 22 had sufficient imaging data to be included in the primary analysis (median age at surgery of 10 years, range 5-18). Fifteen (68.2%) were SF and 7 (31.8%) NSF at median follow-up of 19.5 months (range 12-46). On univariate analysis, histopathology, was the only significant factor associated with SF (p<0.05). The percentage of defined SOZ contacts resected ranged from 25-100% and was not associated with SF (p=0.89). In a binary logistic regression model, it was highly likely that histology was the only independent predictor of outcome, although the interpretation was limited by pseudo-complete separation of the data.
Conclusion Histopathology is a significant predictor of surgical outcomes in children undergoing SEEG-guided resective epilepsy surgery. The percentage of SOZ contacts resected was not associated with SF. Factors such as spatial organisation of the epileptogenic zone, neurophysiological biomarkers and the prospective identification of pathological tissue may therefore play an important role.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
AC is supported by a Great Ormond Street Hospital Children s Charity Surgeon Scientist Fellowship. This work was supported by the National Institute of Health Research/Great Ormond Street Hospital Biomedical Research Centre.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This retrospective study was conducted following approval from the Joint Research Office of Great Ormond Street Hospital & University College London Institute of Child Health (project ID 19BI26). As it was a retrospective study using routinely collected clinical data, formal ethical approval was waived by the Joint Research Office of Great Ormond Street Hospital & University College London Institute of Child Health.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Declarations of interest: none
Data Availability
N/A
Abbreviations
- SF
- Seizure freedom
- iEEG
- Intracranial electroencephalography
- SEEG
- Stereoelectroencephalography
- MRI
- Magnetic resonance imaging
- SOZ
- Seizure onset zone SF Seizure freedom
- HFO
- High frequency oscillations
- PLHG
- Phase-locked high gamma
- CT
- Computerised tomography
- SOP
- Seizure onset patterns
- LVFA
- Low voltage fast activity
- NSF
- Not-seizure free
- FCD
- Focal cortical dysplasia
- HS
- Hippocampal sclerosis
